Call for applications for the right to study for doctoral degree in the Faculty of Medicine will open on January 25, 2016. Period for applying is January 25 – February 12, 2016.
The Hospital District of Southwest Finland, the University of Turku, Åbo Akademi University, Turku University of Applied Sciences and Novia University of Applied Sciences have made an agreement on developing the campus area around Turku University Hospital. The development is carried out, for example, in research and education under the University Health Campus Turku brand.
Turku PET Centre is taking a giant leap into a new era. The Centre has purchased a new cyclotron and now it can produce radioactive isotopes much faster than before. Now, Turku is climbing to the top in positron emission tomography (PET) on a worldwide scale.
On October 27–28, the joint Finnish-Indian symposium “Future Opportunities in Health, Drug Development and Diagnostics” explored future possibilities in the fields of health, diagnostics, drug development and biomaterials.
.jpg)
”India offers expanding resources and top pharmaceutical professionals to Finnish investors”, emphasized the Indian Ambassador Shri. Ashok Kumar Sharma.
Researchers from Turku, Finland, have developed a compound that boosts the immunity system and prevents allergic reaction to pollen with unparalleled efficiency in preclinical tests.
A new study from the University of Turku shows that intracellular receptor signalling sustains cancer cells that have detached from the surrounding tissue. When the signalling is prevented, the cells cannot spread to other parts of the body. This significant research result influences how cancer research is directed in the future.
The research group led by Academy Professor Johanna Ivaska has discovered that cancer cells detached from the surrounding tissue can survive and spread cancer.
The Faculty of Medicine and the doctoral programmes open a call for a grant (1-3 months full-time working) to support doctoral candidates who are in the final stages of their doctoral degrees.
University of Turku researchers developed a winning solution for predicting overall survival of patients with metastatic castrate resistant prostate cancer (mCRPC), treated with first-line anti-mitotic chemotherapy. The primary benefit of this Challenge will be to establish new quantitative benchmarks for prognostic modeling in mCRPC, with a potential impact for clinical decision making and ultimately improving the design of future clinical trials.
The office of the faculty of medicine is closed from 6 to 26 July 2015.
The delegation from Al-Ghad International Colleges for Health Sciences (AICHS) visited the University of Turku to gain information about organising Master’s level education in Health and Nursing Sciences.